Neurocrine Biosciences (NBIX) Net Shares Issued and Repurchased (2010 - 2019)

Neurocrine Biosciences (NBIX) has reported Net Shares Issued and Repurchased for 10 consecutive years, with $1.4 million the latest figure, recorded in Q4 2019.

• For the quarter ending Q4 2019, Net Shares Issued and Repurchased rose 36.15% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2019 stood at $1.4 million (up 36.15% YoY), and the FY2019 full-year result was $1.4 million, up 36.15% from the prior year.
• Net Shares Issued and Repurchased advanced to $1.4 million in Q4 2019 per NBIX's latest filing, from $1.0 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $1.8 million in Q4 2017 and bottomed at $87000.0 in Q4 2015.
• Historically, Net Shares Issued and Repurchased has averaged $1.1 million across 5 years, with a median of $1.1 million in 2016.
• The sharpest annual moves came in 2016 and 2018: Net Shares Issued and Repurchased surged 1137.93% in 2016, then slumped 42.45% in 2018.
• Over 5 years, Net Shares Issued and Repurchased stood at $87000.0 in 2015, then soared by 1137.93% to $1.1 million in 2016, then surged by 67.78% to $1.8 million in 2017, then plunged by 42.45% to $1.0 million in 2018, then soared by 36.15% to $1.4 million in 2019.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1.4 million, $1.0 million, and $1.8 million for Q4 2019, Q4 2018, and Q4 2017 respectively.